Long-Term Safety and Efficacy of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules, a Novel Formulation Containing Morphine and.

Slides:



Advertisements
Similar presentations
Treatment of postherpetic neuralgia: a review of therapeutic options Charles E. Argoff, MD, Nathaniel Katz, MD, Miroslav Backonja, MD Journal of Pain and.
Advertisements

Validation of the Wisconsin Brief Pain Questionnaire in a Multilingual South African Population Noko Mphahlele, MSc, Duncan Mitchell, PhD, Peter Kamerman,
Using a Morphine Equivalence Metric to Quantify Opioid Consumption: Examining the Capacity to Provide Effective Treatment of Debilitating Pain at the Global,
Comparison of the Constipation Assessment Scale and Plain Abdominal Radiography in the Assessment of Constipation in Advanced Cancer Patients Kittiphon.
Chronic Pain Management in Older Adults: Special Considerations
Managing Metastatic Bone Pain: The Role of Bisphosphonates
Carmelita P. Escalante, MD, Michael A. Kallen, PhD, MPH, Rosalie U
Managing Metastatic Bone Pain: The Role of Bisphosphonates
Wen Jing Chung, MD, MS, Gregory H. Pharo, DO 
The Public Health Strategy for Palliative Care
Chronic Pain Management in Older Adults: Special Considerations
A Case Series of Patients Using Medicinal Marihuana for Management of Chronic Pain Under the Canadian Marihuana Medical Access Regulations  Mary E. Lynch,
Opioids for Cancer Breakthrough Pain: A Pilot Study Reporting Patient Assessment of Time to Meaningful Pain Relief  Giovambattista Zeppetella, FRCP  Journal.
Long-Term Opioid Therapy for Chronic Noncancer Pain: A Systematic Review and Meta-Analysis of Efficacy and Safety  Meredith Noble, MS, Stephen J. Tregear,
Why Now? Timing and Circumstances of Hastened Deaths
Edmonton, Canada: A Regional Model of Palliative Care Development
Hospice and Palliative Care Development in Africa: A Multi-Method Review of Services and Experiences  David Clark, PhD, Michael Wright, PhD, Jennifer.
David M. Simpson, MD, Lydia Estanislao, MD, Stephen J
Establishing Mild, Moderate, and Severe Scores for Cancer-Related Symptoms: How Consistent and Clinically Meaningful Are Interference-Based Severity Cut-Points? 
What Palliative Care-Related Problems Do Patients Experience at HIV Diagnosis? A Systematic Review of the Evidence  Victoria M. Simms, MSc, Irene J. Higginson,
Consistency of Efficacy, Patient Acceptability, and Nasal Tolerability of Fentanyl Pectin Nasal Spray Compared with Immediate-Release Morphine Sulfate.
The Effect of Severe Androgen Deficiency on Physical Function in Male Patients With Cancer  Bruno Gagnon, MD, MSc, Jessica Murphy, MSc, Marta Jelowicki,
Clearance of Meperidine and Its Metabolite Normeperidine in Hemodialysis Patients With Chronic Noncancer Pain  Che-Hao Hsu, MD, Tso-Chou Lin, MD, Chih-Cherng.
Eduardo Bruera, MD, Raul Sala, MD, Odette Spruyt, MD, J
Double-Blind, Placebo-Controlled Trial of Lamotrigine in Combination with Other Medications for Neuropathic Pain  Marianne Silver, MS, David Blum, MD,
Long-Term Safety of NGX-4010, a High-Concentration Capsaicin Patch, in Patients with Peripheral Neuropathic Pain  David M. Simpson, MD, Suzanne Gazda,
Self-Reported Constipation in Patients With Advanced Cancer: A Preliminary Report  Wadih Rhondali, MD, Linh Nguyen, MD, Lynn Palmer, PhD, Duck-Hee Kang,
David M. Dosa, MD, MPH, David D
The Direct and Indirect Costs of Opioid-Induced Constipation
Got Volunteers? Association of Hospice Use of Volunteers With Bereaved Family Members' Overall Rating of the Quality of End-of-Life Care  Eve M. Block,
Qiuling Shi, MD, PhD, MSc, Peter C
African American Bereaved Family Members' Perceptions of the Quality of Hospice Care: Lessened Disparities, But Opportunities to Improve Remain  Ramona.
Content Development for the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM): Use of Qualitative and Quantitative Methods for Scale.
Temporary Sympathectomy in the Treatment of Chronic Refractory Angina
Development of a Brief Survey to Measure Nursing Home Residents' Perceptions of Pain Management  Joan M. Teno, MD, MS, David Dosa, MD, MPH, Therese Rochon,
Life-Sustaining Treatment Preferences: Matches and Mismatches Between Patients' Preferences and Clinicians' Perceptions  Lois Downey, MA, David H. Au,
Parent Perceptions of Child Vulnerability Are Associated With Functioning and Health Care Use in Children With Chronic Pain  Mark Connelly, PhD, Kelly.
David Clark, PhD, Michael Wright, PhD 
Redefining Appropriate Treatment Expectations
Clinical Response to an Outpatient Palliative Care Consultation in Patients With Advanced Cancer and Cancer Pain  Sriram Yennurajalingam, MD, Jung Hun.
Amy Z. Boelk, PhD, MSSW, Betty J. Kramer, PhD, MSSW 
Changes in Symptom Intensity Among Cancer Patients Receiving Outpatient Palliative Care  Jung Hun Kang, MD, PhD, Jung Hye Kwon, MD, PhD, David Hui, MD,
Jodi L. Hannan, MD, Steven M. Radwany, MD, Terry Albanese, PhD 
The Role of Patients' Expectations in the Development of Anticipatory Nausea Related to Chemotherapy for Cancer  Jane T. Hickok, MD, MPH, Joseph A. Roscoe,
Barrie R. Cassileth, PhD, Andrew J. Vickers, PhD 
One, Two, or Three? Constructs of the Brief Pain Inventory Among Patients With Non- Cancer Pain in the Outpatient Setting  Kate L. Lapane, PhD, Brian J.
Robert L. Jayes, MD, Robert M. Arnold, MD, Erik K. Fromme, MD 
Susan C. Miller, PhD, Dan K. Kiely, MPH, MA, Joan M
Do Interference-Based Cut-Points Differentiate Mild, Moderate, and Severe Levels of 16 Cancer-Related Symptoms Over Time?  Sangchoon Jeon, MS, Charles.
Safety and Tolerability of Once-Daily OROS® Hydromorphone Extended-Release in Opioid-Tolerant Adults With Moderate-to-Severe Chronic Cancer and Noncancer.
Evaluation of the FICA Tool for Spiritual Assessment
U.S. Hospice Benefits Journal of Pain and Symptom Management
Is the B12/CRP Index More Accurate Than You at Predicting Life Expectancy in Advanced Cancer Patients?  Filipa Tavares, MD  Journal of Pain and Symptom.
Development and Reliability Testing of the Victoria Bowel Performance Scale (BPS)  G. Michael Downing, MD, Craig Kuziemsky, PhD, Mary Lesperance, PhD,
Association Between Symptom Distress and Survival in Outpatients Seen in a Palliative Care Cancer Center  J. Lynn Palmer, PhD, Michael J. Fisch, MD, MPH 
Margot E. Kurtz, PhD, Jay C. Kurtz, PhD, Charles W
Comparative Efficacy of Oral Extended-Release Hydromorphone and Immediate- Release Hydromorphone in Patients with Persistent Moderate to Severe Pain: Two.
Carmen R. Green, MD, Laura Montague, BS, Tamera A. Hart-Johnson, MS 
Perceived Success in Addressing End-of-Life Care Needs of Low-Income Elders and Their Families: What Has Family Conflict Got to Do With It?  Betty J.
Psychometric update of the Functional Interference Estimate: a brief measure of pain functional interference  Robert J. Ferguson, PhD, Janette Seville,
Clinical and Economic Impact of Palliative Care Consultation
A Meta-Analysis of the Relationship Between Response Expectancies and Cancer Treatment-Related Side Effects  Stephanie J. Sohl, PhD, Julie B. Schnur,
Hydromorphone Journal of Pain and Symptom Management
Development of a Brief Survey to Measure Nursing Home Residents' Perceptions of Pain Management  Joan M. Teno, MD, MS, David Dosa, MD, MPH, Therese Rochon,
Botucatu, Brazil: A Regional Community Palliative Care Model
Long-Term Opioid Therapy for Chronic Noncancer Pain: A Systematic Review and Meta-Analysis of Efficacy and Safety  Meredith Noble, MS, Stephen J. Tregear,
Helping Patients with Advanced Cancer Live with Concerns About Eating: A Challenge for Palliative Care Professionals  Jane Hopkinson, PhD, RGN, Jessica.
Cancer Symptom Clusters: A Validation Study
Associations Between Physical Activity and Quality of Life in Cancer Patients Receiving Palliative Care: A Pilot Survey  Sonya S. Lowe, MD, MSc, Sharon.
Physical Activity Behaviors in Individuals with Multiple Sclerosis: Roles of Overall and Specific Symptoms, and Self-Efficacy  Erin M. Snook, MS, Robert.
Presentation transcript:

Long-Term Safety and Efficacy of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules, a Novel Formulation Containing Morphine and Sequestered Naltrexone, in Patients with Chronic, Moderate to Severe Pain  Lynn R. Webster, MD, Randall Brewer, MD, Chao Wang, PhD, Doreen Sekora, MPH, Franklin K. Johnson, MS, David Morris, PhD, Joseph Stauffer, DO, MBA  Journal of Pain and Symptom Management  Volume 40, Issue 5, Pages 734-746 (November 2010) DOI: 10.1016/j.jpainsymman.2010.05.004 Copyright © 2010 U.S. Cancer Pain Relief Committee Terms and Conditions

Fig. 1 Patient disposition. Journal of Pain and Symptom Management 2010 40, 734-746DOI: (10.1016/j.jpainsymman.2010.05.004) Copyright © 2010 U.S. Cancer Pain Relief Committee Terms and Conditions

Fig. 2 Mean percent change from baseline in average, worst, least, and current pain over duration of study for (a) ITT and (b) completer populations. aIncludes 2 patients who did not complete the study but provided assessments at week 52 visit. Journal of Pain and Symptom Management 2010 40, 734-746DOI: (10.1016/j.jpainsymman.2010.05.004) Copyright © 2010 U.S. Cancer Pain Relief Committee Terms and Conditions

Fig. 3 Mean (standard error of the mean) plasma morphine concentrations over duration of study (patients in PK substudy [n=93]). Journal of Pain and Symptom Management 2010 40, 734-746DOI: (10.1016/j.jpainsymman.2010.05.004) Copyright © 2010 U.S. Cancer Pain Relief Committee Terms and Conditions